Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance

被引:1
|
作者
Gale, MJ
Korth, MJ
Katze, MG [1 ]
机构
[1] Univ Washington, Sch Med, Reg Primate Res Ctr, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA
来源
CLINICAL AND DIAGNOSTIC VIROLOGY | 1998年 / 10卷 / 2-3期
关键词
HCV; NS5A; ISDR; PKR; interferon-alpha (IFN);
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Chronic infection with hepatitis C virus (HCV) is associated with progressive liver damage, including the development of cirrhosis and hepatocellular carcinoma, and HCV is a leading cause of liver dysfunction worldwide. The current therapy for chronic HCV infection, interferon-a (IFN), is effective in a minority of HCV-infected patients. Several studies have demonstrated a correlation between therapeutic outcome and the amino acid sequence of a small region of the HCV non-structural 5A (NS5A) gene product. It has been suggested that this region, termed the interferon sensitivity-determining region (ISDR), may mediate IFN resistance by directly interacting with one or more cellular proteins associated with the IFN-mediated antiviral response. Objectives: In an attempt to define the molecular mechanism by which the NS5A protein and the ISDR might contribute to HCV resistance to IFN, we examined whether NS5A could regulate the IFN-induced protein kinase, PKR, a primary mediator of the IFN-induced antiviral response. Study design: Multiple approaches, including in vitro assays using recombinant proteins, the transfection of recombinant clones into cultured cells, and in vivo studies in yeast, were used to examine the interaction of NS5A with PKR, as well as the functional significance of the interaction. An ISDR deletion mutant was prepared to evaluate the importance of the ISDR in mediating the NS5A-PKR interaction and the requirement of this region for PKR inhibition. Results: NS5A repressed PKR activity through a direct interaction with the protein kinase catalytic domain. Both PKR repression and interaction required the presence of the ISDR. Conclusions: Inactivation of PKR may be one mechanism by which HCV avoids the antiviral effects of IFN. Thus, therapeutic strategies designed to block the NS5A-PKR interaction may increase the efficacy of IFN therapy in HCV-infected individuals. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 50 条
  • [1] Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein
    Gale, MJ
    Korth, MJ
    Tang, NM
    Tan, SL
    Hopkins, DA
    Dever, TE
    Polyak, SJ
    Gretch, DR
    Katze, MG
    VIROLOGY, 1997, 230 (02) : 217 - 227
  • [2] Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase
    Gale, M
    Kwieciszewski, B
    Dossett, M
    Nakao, H
    Katze, MG
    JOURNAL OF VIROLOGY, 1999, 73 (08) : 6506 - 6516
  • [3] Hepatitis C virus (HCV) NS5A protein:: role in HCV replication and resistance to interferon-α
    Pawlotsky, JM
    JOURNAL OF VIRAL HEPATITIS, 1999, 6 : 47 - 48
  • [4] Hepatitis C virus NS5A protein is phosphorylated by casein kinase II
    Kim, J
    Lee, D
    Choe, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (03) : 777 - 781
  • [5] The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon
    Song, J
    Fujii, M
    Wang, F
    Itoh, M
    Hotta, H
    JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 879 - 886
  • [6] Quantifying the Evolutionary Constraints and Potential of Hepatitis C Virus NS5A Protein
    Dai, Lei
    Du, Yushen
    Qi, Hangfei
    Huber, Christian D.
    Chen, Dongdong
    Zhang, Tian-Hao
    Wu, Nicholas C.
    Wang, Ergang
    Lloyd-Smith, James O.
    Sun, Ren
    MSYSTEMS, 2021, 6 (02)
  • [7] Hepatitis C virus non-structural protein NS5A is phosphorylated by protein kinase A.
    Ide, Y
    Sasaguri, Y
    Padmanabhan, R
    FASEB JOURNAL, 1996, 10 (06): : 1550 - 1550
  • [8] The α isoform of protein kinase CKI is responsible for hepatitis C virus NS5A hyperphosphorylation
    Quintavalle, Manuela
    Sambucini, Sonia
    Di Pietro, Chiara
    De Francesco, Raffaele
    Neddermann, Petra
    JOURNAL OF VIROLOGY, 2006, 80 (22) : 11305 - 11312
  • [9] Antigenic heterogeneity of the hepatitis C virus NS5A protein
    Dou, XG
    Talekar, G
    Chang, J
    Dai, X
    Li, LX
    Bonafonte, MT
    Holloway, B
    Fields, HA
    Khudyakov, YE
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (01) : 61 - 67
  • [10] The NS5A protein of hepatitis C virus is a zinc metalloprotein
    Tellinghuisen, TL
    Marcotrigiano, J
    Gorbalenya, AE
    Rice, CM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) : 48576 - 48587